Real-world treatment (tx) patterns and clinical outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) in Germany: Results of a retrospective observational study (CONVINCE)

被引：0

作者：

Machtens, Stefan ^{[1
]}

Schlack, Katrin ^{[2
]}

Kubin, Thomas ^{[3
]}

Ruhnke, Markus ^{[4
]}

Schulte, Clemens ^{[5
]}

Eisen, Anna ^{[6
]}

Osowski, Ulrike ^{[7
]}

Guenther, Silke ^{[8
]}

Kearney, Mairead ^{[8
]}

Lipp, Rainer ^{[6
]}

Schmitz, Stephan H. ^{[9
]}

机构：

[1] GFO Hosp Rhein Berg, Marien Hosp, Dept Urol, Bergisch Gladbach, Germany

[2] Univ Hosp Muenster, Dept Urol, Munster, Germany

[3] Clin Sudostbayern AG, Dept Hematol Oncol & Palliat Care, Clin Traunstein, Traunstein, Germany

[4] Helios Clin Aue, Clin Hematol Oncol & Palliat Med, Aue, Germany

[5] Practice Hematol & Oncol, Dortmund, Germany

[6] GermanOncol GmbH, Hamburg, Germany

[7] Merck Healthcare Germany GmbH, Merck KGaA, Weiterstadt, Germany

[8] Healthcare Business Merck KGaA, Darmstadt, Germany

[9] Med Care Ctr Oncol & Hematol, Cologne, Germany

来源：

关键词：

D O I：

10.1200/JCO.2024.42.4_suppl.551

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：551 / 551

页数：1